Incidence of pediatric neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody-associated disease in Denmark 2008‒2018: A nationwide, population-based cohort study

•Pediatric NMOSD and MOG antibody-associated disease are rare.•One-third of anti-MOG-positive children relapsed.•In pediatric ADEM, only anti-MOG-positive children relapsed.•The overall risk of relapse after pediatric ADEM was low. The incidence of pediatric neuromyelitis optica spectrum disorder (N...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Multiple sclerosis and related disorders 2019-08, Vol.33, p.162-167
Hauptverfasser: Boesen, Magnus S., Jensen, Poul E.H., Born, Alfred P., Magyari, Melinda, Nilsson, Anna C., Hoei-Hansen, Christina, Blinkenberg, Morten, Sellebjerg, Finn
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:•Pediatric NMOSD and MOG antibody-associated disease are rare.•One-third of anti-MOG-positive children relapsed.•In pediatric ADEM, only anti-MOG-positive children relapsed.•The overall risk of relapse after pediatric ADEM was low. The incidence of pediatric neuromyelitis optica spectrum disorder (NMOSD) and myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease have not been reported previously. Our aim was to estimate the incidence of pediatric NMOSD and the occurrence of anti-MOG antibody-associated disease in Denmark during 2008–18, and to evaluate the diagnostic usefulness of antibodies against MOG and aquaporin-4 (AQP4) in children
ISSN:2211-0348
2211-0356
DOI:10.1016/j.msard.2019.06.002